Cargando…

Costs of the management of hemophilia A with inhibitors in Spain

INTRODUCTION: Emicizumab is a first-in-class monoclonal antibody, recently authorized for the treatment of hemophilia A with inhibitors. This study aims to estimate the direct and indirect costs of the management of hemophilia A with inhibitors, in adult and pediatric patients, including the prophyl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonanad, Santiago, Álvarez, María Teresa, Núñez, Ramiro, Poveda, José Luis, Gil, Beatriz, Ruíz-Beato, Elena, Durán, Ana, Ivanova, Yoana, Pérez-Román, Inés, González-Domínguez, Almudena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AboutScience 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616192/ https://www.ncbi.nlm.nih.gov/pubmed/36627877 http://dx.doi.org/10.33393/grhta.2021.2234

Ejemplares similares

The Limitations and Unmet Needs of the Five Cornerstones to Guarantee Lifelong Optimization of Prophylaxis in Hemophilia Patients
por: Núñez, Ramiro, et al.
Publicado: (2022)

Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non–small cell lung cancer in Spain
por: Majem, Margarita, et al.
Publicado: (2022)

Experience of Preimplantation Genetic Diagnosis for Hemophilia at the University Hospital Virgen Del Rocío in Spain: Technical and Clinical Overview
por: Fernández, Raquel M., et al.
Publicado: (2015)

HemoKinect: A Microsoft Kinect V2 Based Exergaming Software to Supervise Physical Exercise of Patients with Hemophilia
por: Mateo, Fernando, et al.
Publicado: (2018)

The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis
por: Soto, Inmaculada, et al.
Publicado: (2022)

Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A
por: Bonanad, Santiago, et al.
Publicado: (2021)

Impact of Remdesivir on the Treatment of COVID-19 During the First Wave in Spain
por: Soriano, Alejandro, et al.
Publicado: (2021)

Effectiveness of progressive moderate‐vigorous intensity elastic resistance training on quality of life and perceived functional abilities in people with hemophilia: Secondary analysis of a randomized controlled trial
por: Cruz‐Montecinos, Carlos, et al.
Publicado: (2022)

Hemophilia Burden of Disease: A Systematic Review of the Cost-Utility Literature for Hemophilia
por: Thorat, Teja, et al.
Publicado: (2018)

Costs and utilization of treatment in patients with hemophilia
por: Rocha, Patrícia, et al.
Publicado: (2015)

The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study
por: Delgado-Ortega, Laura, et al.
Publicado: (2018)

Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients
por: Chelle, Pierre, et al.
Publicado: (2019)

Correction to: Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients
por: Chelle, Pierre, et al.
Publicado: (2019)

Impact on healthcare resource utilization of multiple sclerosis in Spain
por: Sicras-Mainar, Antoni, et al.
Publicado: (2017)

Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain
por: Darbà, Josep, et al.
Publicado: (2013)

Complications and Implant Survival of Total Knee Arthroplasty in People with Hemophilia
por: Rodriguez-Merchan, Emerito Carlos, et al.
Publicado: (2022)

Development and Innovation in Cooked Ham Produced in Spain
por: Arenas, Cristian B., et al.
Publicado: (2023)

Continuity of care between hospital pharmacies and community pharmacies, and costs avoided: a pilot experience in times of COVID-19 in Spain
por: Zozaya, Néboa, et al.
Publicado: (2021)

Prophylaxis therapy with bypassing agents in patients with haemophilia A and inhibitors undergoing surgery: A cost analysis in Spain
por: Mareque, María, et al.
Publicado: (2020)

The social return on investment of a new approach to heart failure in the Spanish National Health System
por: Merino, María, et al.
Publicado: (2020)

Burden of disease due to cancer in Spain
por: Fernández de Larrea-Baz, Nerea, et al.
Publicado: (2009)

Comorbidity and metabolic syndrome in patients with multiple sclerosis from Asturias and Catalonia, Spain
por: Sicras-Mainar, Antoni, et al.
Publicado: (2017)

Cost of early-stage mycosis fungoides treatments in Spain
por: Ortiz-Romero, Pablo Luis, et al.
Publicado: (2020)

Pattern of healthcare resource utilization and direct costs associated with manic episodes in Spain
por: Tafalla, Monica, et al.
Publicado: (2010)

Situation of Neuromarketing Consulting in Spain
por: Núñez-Cansado, Marian, et al.
Publicado: (2020)

Epidemiology, Quality of Life, and Costs Associated with Hypoglycemia in Patients with Diabetes in Spain: A Systematic Literature Review
por: Núñez, Mercedes, et al.
Publicado: (2019)

Long-term impact of primary prophylaxis on joint status in patients with severe hemophilia A
por: Meijón Ortigueira, María del Mar, et al.
Publicado: (2023)

Dramatic Impact of the COVID-19 Outbreak on Donation and Transplantation Activities in Spain()
por: Domínguez-Gil, Beatriz, et al.
Publicado: (2020)

Costs and healthcare utilisation of patients with heart failure in Spain
por: Escobar, Carlos, et al.
Publicado: (2020)

"DARK SKIN"-ACQUIRED HEMOPHILIA A AFTER PFIZER-BIONTECH COVID-19 VACCINE
por: GONZALEZ, RUBEN, et al.
Publicado: (2021)

Cost of Disorders of the Brain in Spain
por: Parés-Badell, Oleguer, et al.
Publicado: (2014)

Bovine tuberculosis in Spain, is it really the final countdown?
por: Bezos, Javier, et al.
Publicado: (2023)

Quality of Life, Perception of Disease and Coping Strategies in Patients with Hemophilia in Spain and El Salvador: A Comparative Study
por: Cuesta-Barriuso, Rubén, et al.
Publicado: (2021)

Practice of Iranian Adolescents with Hemophilia in Prevention of Complications of Hemophilia
por: Valizadeh, Leila, et al.
Publicado: (2015)

Cost-effectiveness analysis of chronic hepatitis C treatment in the prison population in Spain
por: Marco, A, et al.
Publicado: (2020)

Economic valuation of informal care in cerebrovascular accident survivors in Spain
por: Oliva-Moreno, Juan, et al.
Publicado: (2013)

Juvenile idiopathic arthritis: cross-sectional study of incidence and prevalence observed in a tertiary center of spain
por: San Ildefonso, Marta Medrano, et al.
Publicado: (2014)

Single-Parent Families, Educational Gradient, and Child Deprivation: The Cases of Italy and Spain
por: Pérez-Corral, Antonio L., et al.
Publicado: (2022)

Effects of the COVID-19 pandemic on perinatal mental health in Spain: Positive and negative outcomes
por: Chaves, Covadonga, et al.
Publicado: (2022)

Hemophilia C management in obstetric anesthesia
por: Guadalix-Sanchez, Cristina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_if99uaefprqjnos1gcfqt5e87f